Nuveen Asset Management, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$49,324,579
-1.1%
3,108,039
+17.6%
0.02%0.0%
Q2 2023$49,864,616
+406526.6%
2,642,534
-17.3%
0.02%
+240.0%
Q1 2023$12,263
+91.9%
3,193,514
+147.9%
0.01%
+150.0%
Q4 2022$6,390
-99.8%
1,288,180
+97.0%
0.00%
+100.0%
Q3 2022$3,126,000
-27.5%
654,039
-31.8%
0.00%
-50.0%
Q2 2022$4,313,000
-54.2%
958,551
-56.2%
0.00%
-33.3%
Q1 2022$9,417,000
+98.4%
2,190,057
+182.6%
0.00%
+200.0%
Q4 2021$4,747,000
-1.4%
774,966
-6.6%
0.00%0.0%
Q3 2021$4,814,000
-18.4%
830,023
-7.3%
0.00%
-50.0%
Q2 2021$5,898,000
-20.0%
894,915
-1.7%
0.00%0.0%
Q1 2021$7,377,000
+32.8%
910,771
+5.8%
0.00%0.0%
Q4 2020$5,553,000
+84.9%
860,912
+3.2%
0.00%
+100.0%
Q3 2020$3,003,000
-32.7%
834,303
-13.9%
0.00%
-50.0%
Q2 2020$4,460,000
-0.5%
969,523
-26.3%
0.00%0.0%
Q1 2020$4,484,000
+34.3%
1,315,006
+101.1%
0.00%
+100.0%
Q4 2019$3,338,000
+100.1%
653,757
-5.1%
0.00%0.0%
Q3 2019$1,668,000
+8.9%
688,945
-2.4%
0.00%0.0%
Q2 2019$1,532,000
+719.3%
705,551
+921.0%
0.00%0.0%
Q1 2019$187,000
-43.7%
69,1020.0%0.00%
-50.0%
Q4 2018$332,000
-49.2%
69,1020.0%0.00%
-33.3%
Q3 2018$654,000
+8.5%
69,102
+11.5%
0.00%
-25.0%
Q2 2018$603,000
-7.5%
61,9490.0%0.00%0.0%
Q1 2018$652,000
+64.2%
61,9490.0%0.00%
+33.3%
Q4 2017$397,000
-16.2%
61,9490.0%0.00%0.0%
Q3 2017$474,000
+3.0%
61,949
-4.3%
0.00%0.0%
Q2 2017$460,000
+72.3%
64,749
-6.1%
0.00%
+50.0%
Q1 2017$267,000
+86.7%
68,928
-1.6%
0.00%
+100.0%
Q4 2016$143,000
-23.9%
70,023
-0.4%
0.00%0.0%
Q3 2016$188,000
-13.4%
70,3230.0%0.00%0.0%
Q2 2016$217,000
-63.9%
70,323
-0.4%
0.00%
-66.7%
Q1 2016$601,000
+264.2%
70,588
+479.7%
0.00%
+200.0%
Q4 2015$165,000
+38.7%
12,177
-2.0%
0.00%0.0%
Q3 2015$119,000
-33.5%
12,4240.0%0.00%0.0%
Q2 2015$179,000
+57.0%
12,424
-2.2%
0.00%0.0%
Q1 2015$114,000
+46.2%
12,7050.0%0.00%
Q4 2014$78,000
-43.9%
12,705
-3.0%
0.00%
-100.0%
Q3 2014$139,000
-10.3%
13,0940.0%0.00%0.0%
Q2 2014$155,000
-20.5%
13,0940.0%0.00%0.0%
Q1 2014$195,000
+1.6%
13,0940.0%0.00%0.0%
Q4 2013$192,000
-10.3%
13,094
+4.1%
0.00%0.0%
Q3 2013$214,000
-79.2%
12,584
-79.7%
0.00%
-85.7%
Q2 2013$1,029,00062,0750.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 17,503,417$277,779,22813.22%
Fairmount Funds Management LLC 5,929,592$94,102,62511.32%
CM Management, LLC 500,000$7,935,0008.42%
SILVERARC CAPITAL MANAGEMENT, LLC 1,307,435$20,748,9936.29%
Altium Capital Management LP 725,000$11,505,7506.00%
RA Capital Management 13,322,288$211,424,7114.16%
TANG CAPITAL MANAGEMENT LLC 1,500,000$23,805,0003.36%
BRIDGER MANAGEMENT, LLC 467,220$7,414,7812.73%
Birchview Capital, LP 190,000$3,015,3002.57%
Boxer Capital, LLC 2,961,000$46,991,0702.50%
View complete list of IMMUNOGEN INC shareholders